Department for Urology

Publications

  1. SCORING: Journal article › Research › Peer-reviewed
  2. Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management

    Pose, R. M., Knipper, S., Ekrutt, J., Kölker, M., Tennstedt, P., Heinzer, H., Tilki, D., Langer, F. & Graefen, M., 01.2024, In: ASIAN J UROL. 11, 1, p. 42-47 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Primäres diffuses Neurofibrom der Harnblase: Ein seltener Fallbericht und Literaturübersicht

    Rink, M., Minner, S. J. P., Tsourlakis, M. C., Wilczak, W., Fisch, M. & Dahlem, R., 01.11.2010, In: UROLOGE. 49, 11, p. 1398-1400 3 p., 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Primary Ta high grade bladder tumors: Determination of the risk of progression

    Quhal, F., D'Andrea, D., Soria, F., Moschini, M., Abufaraj, M., Rouprêt, M., Karakiewicz, P. I., Yang, L., Mostafaei, H., Laukhtina, E., Mori, K., Sari Motlagh, R., Rink, M. & Shariat, S. F., 02.2021, In: UROL ONCOL-SEMIN ORI. 39, 2, p. 132.e7-132.e11

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. [Pro and contra: 11C choline PET in diagnosis of prostate cancer]

    Kotzerke, J., Zöphel, K., Salomon, G., Graefen, M. & Heidenreich, A., 2007, In: AKTUEL UROL. 38, 3, p. 189-194 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. [Problems, objective, and substance of early detection of prostate cancer].

    Börgermann, C., Loertzer, H., Hammerer, P., Fornara, P., Graefen, M. & Rübben, H., 2010, In: UROLOGE. 49, 2, p. 181-189 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

    Kluth, L. A., Black, P. C., Bochner, B. H., Catto, J., Lerner, S. P., Stenzl, A., Sylvester, R., Vickers, A. J., Xylinas, E. & Shariat, S. F., 08.2015, In: EUR UROL. 68, 2, p. 238-53 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma

    Laukhtina, E., Pradere, B., D'Andrea, D., Rosiello, G., Luzzago, S., Pecoraro, A., Palumbo, C., Knipper, S., Karakiewicz, P. I., Margulis, V., Quhal, F., Motlagh, R. S., Mostafaei, H., Mori, K., Schuettfort, V. M., Enikeev, D. & Shariat, S. F., 02.2021, In: TRANSL ANDROL UROL. 10, 2, p. 609-619 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma

    Laukhtina, E., Pradere, B., D'Andrea, D., Rosiello, G., Luzzago, S., Pecoraro, A., Palumbo, C., Knipper, S., Karakiewicz, P. I., Margulis, V., Quhal, F., Sari Motlagh, R., Mostafaei, H., Mori, K., Schuettfort, V. M., Enikeev, D. & Shariat, S. F., 06.2022, In: MINERVA UROL NEPHROL. 74, 3, p. 329-336 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma

    Gakis, G., Morgan, T. M., Efstathiou, J. A., Keegan, K. A., Mischinger, J., Todenhoefer, T., Schubert, T., Zaid, H. B., Hrbacek, J., Ali-El-Dein, B., Clayman, R. H., Galland, S., Olugbade, K., Rink, M., Fritsche, H-M., Burger, M., Chang, S. S., Babjuk, M., Thalmann, G. N., Stenzl, A. & Daneshmand, S., 01.2016, In: WORLD J UROL. 34, 1, p. 97-103

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer

    Mori, K., Sharma, V., Comperat, E. M., Sato, S., Laukhtina, E., Schuettfort, V. M., Pradere, B., Sari Motlagh, R., Mostafaei, H., Quhal, F., Kardoust Parizi, M., Abufaraj, M., Karakiewicz, P. I., Egawa, S., Tilki, D., Boorjian, S. A. & Shariat, S. F., 12.2021, In: ANN SURG ONCOL. 28, 13, p. 9179-9187 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series

    May, M., Aziz, A., Brookman-May, S., Roghmann, F., Noldus, J., Rink, M., Chun, F., Fisch, M., Novotny, V., Wirth, M., Mayr, R., Pycha, A., Brisuda, A., Volkmer, B., Stredele, R., Dechet, C., Vallo, S., Haferkamp, A., Schnabel, M., Denzinger, S., Roigas, J., Stief, C. G., Gilfrich, C., Bastian, P. J., Engel, J. B., Burger, M. & Fritsche, H-M., 01.03.2014, In: WORLD J UROL. 33, 3, p. 343-350

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy

    Sari Motlagh, R., Schuettfort, V. M., Mori, K., Katayama, S., Rajwa, P., Aydh, A., Grossmann, N. C., Laukhtina, E., Pradere, B., Mostafai, H., Quhal, F., Abufaraj, M., Lee, R., Karakiewicz, P. I., Lotan, Y., Comprate, E., Moschini, M., Gontero, P. & Shariat, S. F., 07.2022, In: INT J UROL. 29, 7, p. 676-683 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy

    Schuettfort, V. M., Pradere, B., D'Andrea, D., Grossmann, N. C., Quhal, F., Mostafaei, H., Laukhtina, E., Mori, K., Rink, M., Karakiewicz, P. I., Motlagh, R. S., Katayama, S., Lotan, Y., Scherr, D., Abufaraj, M., Fajkovica, H., Compérat, E., Enikeev, D. & Shariat, S. F., 11.2021, In: J UROLOGY. 206, 5, p. 1122-1131 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. [Prognostic markers for prostate cancer]

    Graefen, M., Hammerer, P., Noldus, J., Haese, A., Pichelmeier, U., Erbersdobler, A., Henke, H., Conrad, S., Fernandez, S. & Huland, H., 2000, In: UROLOGE. 39, 1, p. 14-21 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy

    Kluth, L. A., Xylinas, E., Rieken, M., Kent, M., Ikeda, M., Matsumoto, K., Hagiwara, M., Kikuchi, E., Bing, M. T., Gupta, A., Sewell, J. M., Konety, B. R., Todenhöfer, T., Schwentner, C., Masson-Lecomte, A., Vordos, D., Roghmann, F., Noldus, J., Razmaria, A. A., Smith, N. D., Comploj, E., Pycha, A., Rink, M., Baniel, J., Mano, R., Novara, G., Aziz, A., Fritsche, H-M., Brisuda, A., Bivalacqua, T., Gontero, P., Boorjian, S. A., Vickers, A. J. & Shariat, S. F., 08.2015, In: EUR UROL FOCUS. 1, 1, p. 75-81 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer

    Aziz, A., Kempkensteffen, C., May, M., Lebentrau, S., Burger, M., Chun, F. K-H. & Brookman-May, S., 06.2015, In: EXPERT REV ANTICANC. 15, 6, p. 649-66 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.

    Fleischmann, A., Huland, H., Mirlacher, M., Wilczak, W., Simon, R., Erbersdobler, A., Sauter, G. & Schlomm, T., 2012, In: PROSTATE. 72, 9, p. 991-997 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

    Friedrich, M., Chandrasoma, S., Siegmund, K. D., Weisenberger, D. J., Cheng, J. C., Toma, M. I., Huland, H., Jones, P. A. & Liang, G., 2005, In: EUR J CANCER. 41, 17, p. 2769-2778 17.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy

    Gakis, G., Fritsche, H-M., Hassan, F., Kluth, L., Miller, F., Soave, A., Otto, W., Schwentner, C., Todenhöfer, T., Dahlem, R., Burger, M., Fisch, M., Stenzl, A., Aziz, A. & Rink, M., 01.10.2014, In: EUR J CANCER. 50, 15, p. 2583-2591 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.

    Rink, M., Chun, F., Dahlem, R., Soave, A., Minner, S. J. P., Hansen, J., Stoupiec, M., Coith, C., Kluth, L., Ahyai, S., Friedrich, M. G., Shariat, S. F., Fisch, M., Pantel, K. & Riethdorf, S., 2012, In: EUR UROL. 61, 4, p. 810-817 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

    Favaretto, R. L., Bahadori, A., Mathieu, R., Haitel, A., Grubmüller, B., Margulis, V., Karam, J. A., Rouprêt, M., Seitz, C., Karakiewicz, P. I., Cunha, I. W., Zequi, S. C., Wood, C. G., Weizer, A. Z., Raman, J. D., Remzi, M., Rioux-Leclercq, N., Jacquet-Kammerer, S., Bensalah, K., Lotan, Y., Bachmann, A., Rink, M., Briganti, A. & Shariat, S. F., 01.2017, In: WORLD J UROL. 35, 1, p. 113-120

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent

    Mbeutcha, A., Lucca, I., Margulis, V., Karam, J. A., Wood, C. G., de Martino, M., Mathieu, R., Haitel, A., Xylinas, E., Kluth, L., Rouprêt, M., Karakiewicz, P. I., Briganti, A., Rink, M., Rieken, M., Weizer, A. Z., Raman, J. D., Rioux-Leclecq, N., Bolenz, C., Bensalah, K., Lotan, Y., Seitz, C., Remzi, M., Shariat, S. F. & Klatte, T., 01.08.2016, In: WORLD J UROL. 34, 8, p. 1155-61

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

    Mori, K., Schuettfort, V. M., Katayama, S., Laukhtina, E., Pradere, B., Quhal, F., Sari Motlagh, R., Mostafaei, H., Grossmann, N. C., Rajwa, P., Teoh, J. Y., Resch, I., Fajkovic, H., Moschini, M., D'andrea, D., Abufaraj, M., Karakiewicz, P. I., Lotan, Y., Scherr, D., Egawa, S., Compérat, E., Shariat, S. F. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 08.2022, In: ANN SURG ONCOL. 29, 8, p. 5307-5316 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

    Mori, K., Resch, I., Miura, N., Laukhtina, E., Schuettfort, V. M., Pradere, B., Katayama, S., D'Andrea, D., Kardoust Parizi, M., Abufaraj, M., Fukuokaya, W., Collà Ruvolo, C., Luzzago, S., Knipper, S., Palumbo, C., Karakiewicz, P. I., Briganti, A., Enikeev, D. V., Rouprêt, M., Margulis, V., Egawa, S. & Shariat, S. F., 09.2021, In: CANCER IMMUNOL IMMUN. 70, 9, p. 2641-2650 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer

    Iwata, T., Kimura, S., Abufaraj, M., Janisch, F., Parizi, M. K., Haitel, A., Rink, M., Rouprêt, M., Fajkovic, H., Seebacher, V., Nyirady, P., Karakiewicz, P. I., Enikeev, D., Rapoport, L. M., Nasu, Y. & Shariat, S. F., 10.2019, In: UROL ONCOL-SEMIN ORI. 37, 10, p. 774-783 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.

    Ahyai, S., Zacharias, M., Isbarn, H., Steuber, T., Eichelberg, C., Köllermann, J., Fisch, M., Karakiewicz, P. I., Huland, H., Graefen, M. & Chun, F., 2010, In: BJU INT. 106, 4, p. 478-483 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer

    Gakis, G., Rink, M., Fritsche, H-M., Graefen, M., Schubert, T., Hassan, F., Chun, F. K., Brummeisl, W., Fisch, M., Burger, M., Stenzl, A. & Renninger, M., 09.01.2016, In: UROL INT. 97, 1, p. 42-8

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.

    Lughezzani, G., Capitanio, U., Jeldres, C., Isbarn, H., Shariat, S. F., Arjane, P., Widmer, H., Perrotte, P., Montorsi, F. & Karakiewicz, P. I., 2009, In: CANCER-AM CANCER SOC. 115, 24, p. 5680-5687 24.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer

    Mbeutcha, A., Shariat, S. F., Rieken, M., Rink, M., Xylinas, E., Seitz, C., Lucca, I., Mathieu, R., Rouprêt, M., Briganti, A., Karakiewicz, P. I. & Klatte, T., 16.09.2016, In: UROL ONCOL-SEMIN ORI. 34, 11, p. 483.e17-483.e24

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era

    Scheipner, L., Barletta, F., Cano Garcia, C., Incesu, R-B., Morra, S., Baudo, A., Assad, A., Tian, Z., Saad, F., Shariat, S. F., Briganti, A., Chun, F. K. H., Tilki, D., Longo, N., Carmignani, L., Pichler, M., Ahyai, S. & Karakiewicz, P. I., 12.2023, In: ANN SURG ONCOL. 30, 13, p. 8780-8785 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy

    Bishoff, J. T., Freedland, S. J., Gerber, L., Tennstedt, P., Reid, J., Welbourn, W., Graefen, M., Sangale, Z., Tikishvili, E., Park, J., Younus, A., Gutin, A., Lanchbury, J. S., Sauter, G., Brawer, M., Stone, S. & Schlomm, T., 01.08.2014, In: J UROLOGY. 192, 2, p. 409-14 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer

    Quhal, F., Pradere, B., Laukhtina, E., Sari Motlagh, R., Mostafaei, H., Mori, K., Schuettfort, V. M., Karakiewicz, P. I., Rouprêt, M., Enikeev, D., Rink, M., Abufaraj, M. & Shariat, S. F., 09.2021, In: WORLD J UROL. 39, 9, p. 3345-3352 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

    Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study

    Mathieu, R., Klatte, T., Lucca, I., Beutcha, A. M., Seitz, C., Karakiewicz, P. I., Fajkovic, H., Sun, M., Lotan, Y., Scherr, D. S., Montorsi, F., Briganti, A., Rouprêt, M., Margulis, V., Rink, M., Kluth, L. A., Rieken, M., Kenner, L., Susani, M., Robinson, B. D., Xylinas, E., Loidl, W. & Shariat, S. F., 01.08.2016, In: BJU INT. 118, 2, p. 243-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

    Katayama, S., Schuettfort, V. M., Pradere, B., Mori, K., Mostafaei, H., Quhal, F., Sari Motlagh, R., Laukhtina, E., Grossmann, N. C., Aydh, A., Rajwa, P., König, F., Karakiewicz, P. I., Haydter, M., Moschini, M., Abufaraj, M., Lotan, Y., Lee, R. K., Trinh, Q-D., Compérat, E., Teoh, J., Nasu, Y. & Shariat, S. F., 11.2022, In: J CANCER RES CLIN. 148, 11, p. 3091-3102 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

    Erbersdobler, A., Isbarn, H., Dix, K., Steiner, I., Schlomm, T., Mirlacher, M., Sauter, G. & Haese, A., 2009, In: WORLD J UROL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer

    Kimura, S., D' Andrea, D., Soria, F., Foerster, B., Abufaraj, M., Vartolomei, M. D., Iwata, T., Karakiewicz, P. I., Rink, M., Gust, K. M., Egawa, S. & Shariat, S. F., 03.2019, In: UROL ONCOL-SEMIN ORI. 37, 3, p. 179.e19-179.e28

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma

    Fritsche, H-M., May, M., Denzinger, S., Otto, W., Siegert, S., Giedl, C., Giedl, J., Eder, F., Agaimy, A., Novotny, V., Wirth, M., Stief, C., Brookman-May, S., Hofstädter, F., Gierth, M., Aziz, A., Kocot, A., Riedmiller, H., Bastian, P. J., Toma, M., Wieland, W. F., Hartmann, A. & Burger, M., 01.04.2013, In: EUR UROL. 63, 4, p. 739-44 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer

    Quhal, F., Pradere, B., Sari Motlagh, R., Mori, K., Laukhtina, E., Aydh, A., Mostafaei, H., Lysenko, I., Schuettfort, V. M., Stolzenbach, F., Palumbo, C., Heidenreich, A., Briganti, A., Karakiewicz, P. I., Chlosta, P. & Shariat, S. F., 10.2021, In: MINERVA UROL NEFROL. 73, 5, p. 610-615 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer

    Kimura, S., Soria, F., D'Andrea, D., Foerster, B., Abufaraj, M., Vartolomei, M. D., Karakiewicz, P. I., Mathieu, R., Moschini, M., Rink, M., Egawa, S., Shariat, S. F. & Gust, K. M., 12.2018, In: CLIN GENITOURIN CANC. 16, 6, p. e1123-e1132

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

    Miura, N., Mori, K., Laukhtina, E., Schuettfort, V. M., Abufaraj, M., Teoh, J. Y. C., Luzzago, S., Stolzenbach, F., Deuker, M., Karakiewicz, P. I., Briganti, A., Enikeev, D. V., Rouprêt, M., Margulis, V., Chlosta, P., Nyirady, P., Babjuk, M., Egawa, S., Saika, T. & Shariat, S. F., 01.07.2021, In: JPN J CLIN ONCOL. 51, 7, p. 1149-1157 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy

    Aydh, A., Mori, K., D'Andrea, D., Motlagh, R. S., Abufaraj, M., Pradere, B., Mostafaei, H., Laukhtina, E., Quhal, F., Karakiewicz, P. I., Luzzago, S., Briganti, A., Trinh, Q-D., Parizi, M. K., Tilki, D., Enikeev, D. V. & Shariat, S. F., 09.2021, In: INT J CLIN ONCOL. 26, 9, p. 1729-1735 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer

    Katayama, S., Mori, K., Pradere, B., Laukhtina, E., Schuettfort, V. M., Quhal, F., Motlagh, R. S., Mostafaei, H., Grossmann, N. C., Rajwa, P., Moschini, M., Mathieu, R., Abufaraj, M., D'Andrea, D., Compérat, E., Haydter, M., Egawa, S., Nasu, Y., Shariat, S. F. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 12.2021, In: WORLD J UROL. 39, 12, p. 4355-4361 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Prognostische und prädiktive molekulare Marker urologischer Tumoren

    Hartmann, K. A., Schlomm, T., Bertz, S., Heinzelmann, J., Hölters, S., Simon, R., Stoehr, R. & Junker, K., 01.04.2014, In: UROLOGE. 53, 4, p. 491-500 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy

    Vartolomei, M. D., Mathieu, R., Margulis, V., Karam, J. A., Rouprêt, M., Lucca, I., Mbeutcha, A., Seitz, C., Karakiewicz, P. I., Fajkovic, H., Wood, C. G., Weizer, A. Z., Raman, J. D., Rioux-Leclercq, N., Haitel, A., Bensalah, K., Rink, M., Briganti, A., Xylinas, E. & Shariat, S. F., 01.2017, In: WORLD J UROL. 35, 1, p. 121-130

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series.

    Sun, M., Abdollah, F., Shariat, S. F., Schmitges, J., Trinh, Q-D., Tian, Z., Jeldres, C., Abdo, A., Bianchi, M., Briganti, A., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2012, In: EJSO-EUR J SURG ONC. 38, 1, p. 80-87 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.

    Hanna, N., Sun, M., Trinh, Q-D., Hansen, J., Bianchi, M., Montorsi, F., Shariat, S. F., Graefen, M., Perrotte, P. & Karakiewicz, P. I., 2012, In: EUR UROL. 61, 4, p. 715-721 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy

    Moschini, M., Soria, F., Mathieu, R., Xylinas, E., D'Andrea, D., Tan, W. S., Kelly, J. D., Simone, G., Tuderti, G., Meraney, A., Krishna, S., Konety, B., Zamboni, S., Baumeister, P., Mattei, A., Briganti, A., Montorsi, F., Galucci, M., Rink, M., Karakiewicz, P. I., Rouprêt, M., Aziz, A., Perry, M., Rowe, E., Koupparis, A., Kassouf, W., Scherr, D. S., Ploussard, G., Boorjian, S. A., Sooriakumaran, P., Shariat, S. F. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 03.2019, In: UROL ONCOL-SEMIN ORI. 37, 3, p. 179.e1-179.e7

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Prospective analysis of artificial urinary sphincter AMS 800 implantation after buccal mucosa graft urethroplasty.

    Maurer, V., Marks, P., Dahlem, R., Rosenbaum, C., Meyer, C., Riechardt, S., Fisch, M. & Ludwig, T. A., 17.01.2019, In: WORLD J UROL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Prospective non-randomized evaluation of four mediators of the systemic response after extraperitoneal laparoscopic and open retropubic radical prostatectomy.

    Jurczok, A., Zacharias, M., Wagner, S., Hamza, A. & Fornara, P., 2007, In: BJU INT. 99, 6, p. 1461-1466 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer. SUSE (AUO-AB 31/05)

    Krege, S., Rexer, H., vom Dorp, F., de Geeter, P., Klotz, T., Retz, M., Heidenreich, A., Kühn, M., Kamradt, J., Feyerabend, S., Wülfing, C., Zastrow, S., Albers, P., Hakenberg, O., Roigas, J., Fenner, M., Heinzer, H. & Schrader, M., 01.03.2014, In: BJU INT. 113, 3, p. 429-436 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers

    Ummanni, R., Duscharla, D., Barett, C., Venz, S., Schlomm, T., Heinzer, H., Walther, R., Bokemeyer, C., Brümmendorf, T. H., Murthy, P. V. L. N. & Balabanov, S., 24.04.2015, In: J PROTEOMICS. 119, p. 218-29 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.

    Leeuwen, V., Kölble, K., Huland, H., Huland, H., Hambrock, T., Barentsz, J. & Schröder, F. H., 2011, In: EUR UROL. 59, 2, p. 183-190 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.

    Chun, F., Karakiewicz, P. I. & Briganti, A., 2008, In: EUR UROL. 54, 2, p. 241-242 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

    Chun, F., de La Taille, A., van Poppel, H., Marberger, M., Stenzl, A., Mulders, P. F. A., Huland, H., Abbou, C-C., Stillebroer, A. B., Gils, V., Martijn, P. M. Q., Schalken, J. A., Fradet, Y., Marks, L. S., Ellis, W., Partin, A. W. & Haese, A., 2009, In: EUR UROL. 56, 4, p. 659-667 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients

    Stolzenbach, L. F., Rosiello, G., Pecoraro, A., Palumbo, C., Luzzago, S., Deuker, M., Tian, Z., Knipper, A-S., Pompe, R., Zorn, K. C., Shariat, S. F., Chun, F. K. H., Graefen, M., Saad, F. & Karakiewicz, P. I., 11.2020, In: J NATL COMPR CANC NE. 18, 11, p. 1492-1499 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  58. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort

    Marra, G., Soria, F., Peretti, F., Oderda, M., Dariane, C., Timsit, M-O., Branchereau, J., Hedli, O., Mesnard, B., Tilki, D., Olsburgh, J., Kulkarni, M., Kasivisvanathan, V., Lebacle, C., Rodriguez-Faba, O., Breda, A., Soeterik, T., Gandaglia, G., Todeschini, P., Biancone, L., Gontero, P. & On Behalf Of The Collaborators, 28.12.2022, In: CANCERS. 15, 1, 189.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. Prostate cancer in the elderly.

    Heinzer, H. & Steuber, T., 2009, In: UROL ONCOL-SEMIN ORI. 27, 6, p. 668-672 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  60. Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml

    Ferro, M., Bruzzese, D., Perdonà, S., Marino, A., Mazzarella, C., Perruolo, G., D'Esposito, V., Cosimato, V., Buonerba, C., Di Lorenzo, G., Musi, G., De Cobelli, O., Chun, F. K. & Terracciano, D., 01.01.2013, In: PLOS ONE. 8, 7, p. e67687

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  61. Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.

    Haese, A., Graefen, M., Huland, H. & Lilja, H., 2004, In: CURR UROL REP. 5, 3, p. 231-240 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. [Prostate-specific antigen for treatment monitoring].

    Graefen, M., Fröhner, M. & Wirth, M., 2011, In: UROLOGE. 50, 3, p. 309-312 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  63. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

    Chun, F., Briganti, A., Gallina, A., Hutterer, G. C., Shariat, S. F., Antebie, E., Walz, J., Roehrborn, C. G., Salonia, A., Rigatti, P., Saad, F., Huland, H., Montorsi, F., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR UROL. 52, 4, p. 1067-1074 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  64. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death

    Tilki, D., Chen, M-H., Wu, J., Huland, H., Graefen, M., Mohamad, O., Cowan, J. E., Feng, F. Y., Carroll, P. R. & D'Amico, A. V., 01.05.2023, In: J CLIN ONCOL. 41, 13, p. 2428-2435 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  65. Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer

    Kim, D. W., Chen, M-H., Wu, J., Huland, H., Graefen, M., Tilki, D. & D'Amico, A. V., 01.07.2021, In: CANCER-AM CANCER SOC. 127, 13, p. 2222-2228 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  66. Prostate-specific membrane antigen radioguided surgery with negative histopathology

    Koehler, D., Trappe, S., Shenas, F., Karimzadeh, A., Apostolova, I., Klutmann, S., Ambrosini, F., Budäus, L., Falkenbach, F., Knipper, S. & Maurer, T., 01.2024, In: EUR J NUCL MED MOL I. 51, 2, p. 548-557 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  67. Prostate volume and adverse prostate cancer features: fact not artifact.

    Briganti, A., Chun, F., Suardi, N., Gallina, A., Walz, J., Graefen, M., Shariat, S., Ebersdobler, A., Rigatti, P., Perrotte, P., Saad, F., Montorsi, F., Huland, H. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 18, p. 2669-2677 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  68. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.

    Haese, A., Graefen, M., Noldus, J., Hammerer, P., Huland, E. & Huland, H., 1997, In: J UROLOGY. 158, 6, p. 2188-2192 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  69. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.

    Seiler, D., Randazzo, M., Leupold, U., Zeh, N., Isbarn, H., Chun, F., Ahyai, S., Baumgartner, M., Huber, A., Recker, F. & Kwiatkowski, M., 2012, In: UROLOGY. 80, 3, p. 564-569 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  70. PSA-Anstieg nach definitiver Therapie

    Maurer, T., Hadaschik, B., Budäus, L., Steuber, T., Salomon, G., Horn, T., Herrmann, K., Weber, M., Giesel, F. L., Berliner, C. & Eiber, M., 05.2019, In: UROLOGE. 58, 5, p. 569-582 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  71. PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?

    Falkenbach, F., Ambrosini, F., Kachanov, M., Ortner, G., Maurer, T., Köhler, D., Beyersdorff, D., Graefen, M. & Budäus, L., 20.03.2024, In: WORLD J UROL. 42, 1, p. 182

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  72. [PSA--Quo vadis?]

    Börgermann, C., Loertzer, H., Luboldt, H-J., Hammerer, P., Fornara, P., Graefen, M. & Rübben, H., 2009, In: UROLOGE. 48, 9, p. 1008, 1010, 1012-1014 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  73. PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

    Heinrich, M-C., Göbel, C., Kluth, M., Bernreuther, C., Sauer, C., Schroeder, C., Möller-Koop, C., Hube-Magg, C., Lebok, P., Burandt, E., Sauter, G., Simon, R., Huland, H., Graefen, M., Heinzer, H., Schlomm, T. & Heumann, A., 31.05.2018, In: BMC CANCER. 18, 1, p. 612

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  74. PSMA expression is highly homogenous in primary prostate cancer

    Tsourlakis, M. C., Klein, F., Kluth, M., Quaas, A., Graefen, M., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 07.2015, In: APPL IMMUNOHISTO M M. 23, 6, p. 449-55 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  75. PSMA-ligand PET for early castration-resistant prostate cancer: a retrospective single-center study

    Weber, M., Kurek, C. E., Barbato, F., Eiber, M., Maurer, T., Nader, M., Hadaschik, B., Grünwald, V., Herrmann, K., Wetter, A. & Fendler, W. P., 01.2021, In: J NUCL MED. 62, 1, p. 88-91 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  76. PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

    Wang, H., Amiel, T., Würnschimmel, C., Langbein, T., Steiger, K., Rauscher, I., Horn, T., Maurer, T., Weber, W., Wester, H-J., Knorr, K. & Eiber, M., 21.08.2021, In: EJNMMI RES. 11, 1, p. 76

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  77. PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy

    Wenzel, M., Hussein, R., Maurer, T., Karakiewicz, P. I., Tilki, D., Graefen, M. & Würnschimmel, C., 01.2022, In: UROL ONCOL-SEMIN ORI. 40, 1, p. 7.e1-7.e8

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  78. PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen: Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krankenhaussektor

    Zippel, C., Giesel, F. L., Kratochwil, C., Eiber, M., Rahbar, K., Albers, P., Maurer, T., Krause, B. J. & Bohnet-Joschko, S., 06.2021, In: NUKLEARMED-NUCL MED. 60, 3, p. 216-223 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  79. Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs

    Kluth, L. A., Dahlem, R., Becker, A., Schmid, M., Soave, A., Rosenbaum, C., Ludwig, T. A., Christ, N., Rink, M., Reiss, P., Engel, O., Riechardt, S., Chun, F. K-H., Fisch, M. & Ahyai, S. A., 03.2016, In: WORLD J UROL. 34, 3, p. 369-375

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  80. [Psychosocial predictors of utilization of medical rehabilitation services among prostate cancer patients].

    Lehmann, C., Beierlein, V., Hagen-Aukamp, C., Kerschgens, C., Rhee, M., Frühauf, S., Otto, J., Graefen, M., Krüll, A., Berger, D., Koch, U. & Bergelt, C., 2012, In: REHABILITATION. 51, 3, p. 160-170 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  81. Psychosomatische Aspekte des chronischen Unterbauchschmerzsyndroms: Psychometrische Ergebnisse der Pilotphase einer interdisziplinären Sprechstunde

    Brünahl, C. A., Riegel, B., Höink, J., Kutup, A., Eichelberg, E. & Löwe, B., 01.06.2014, In: SCHMERZ. 28, 3, p. 311-318 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  82. PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer

    Cordes, I., Kluth, M., Zygis, D., Rink, M., Chun, F., Eichelberg, C., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Wilczak, W., Sauter, G. & Minner, S., 01.11.2013, In: HISTOPATHOLOGY. 63, 5, p. 670-7 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  83. PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

    Lotan, T. L., Heumann, A., Rico, S. D., Hicks, J., Lecksell, K., Koop, C., Sauter, G., Schlomm, T. & Simon, R., 12.09.2017, In: ONCOTARGET. 8, 39, p. 65566-65576 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  84. Quantification of Gleason Pattern 4 at MRI-Guided Biopsy to Predict Adverse Pathology at Radical Prostatectomy in Intermediate-Risk Prostate Cancer Patients

    Kamecki, H., Mielczarek, Ł., Szempliński, S., Dębowska, M., Rajwa, P., Baboudjian, M., Klemm, J., Rivas, J. G., Modzelewska, E., Tayara, O., Malewski, W., Szostek, P., Poletajew, S., Kryst, P., Sosnowski, R. & Nyk, Ł., 17.11.2023, In: CANCERS. 15, 22, 5462.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  85. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.

    Haese, A., Chaudhari, M., Miller, M. C., Epstein, J. I., Huland, H., Palisaar, J., Graefen, M., Hammerer, P., Poole, E. C., O'Dowd, G. J., Partin, A. W. & Veltri, R. W., 2003, In: CANCER-AM CANCER SOC. 97, 4, p. 969-978 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  86. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis

    Leong, J. Y., Herrera-Caceres, J. O., Goldberg, H., Tham, E., Teplitsky, S., Gomella, L. G., Trabulsi, E. J., Lallas, C. D., Fleshner, N. E., Tilki, D. & Chandrasekar, T., 03.2020, In: UROLOGY. 137, p. 102-107 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  87. Rabies post-exposure prophylaxis of international travellers - Results from two major German travel clinics

    Saffar, F., Heinemann, M., Heitkamp, C., Stelzl, D. R., Ramharter, M., Schunk, M., Rothe, C. & Bühler, S., 2023, In: TRAVEL MED INFECT DI. 53, 102573.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  88. Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses

    Jindal, T., Kachroo, N., Sammon, J., Dalela, D., Sood, A., Vetterlein, M. W., Karabon, P., Jeong, W., Menon, M., Trinh, Q-D. & Abdollah, F., 07.2017, In: UROL ONCOL-SEMIN ORI. 35, 7, p. 460.e9-460.e20

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  89. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer

    Schmid, M., Meyer, C. P., Reznor, G., Choueiri, T. K., Hanske, J., Sammon, J. D., Abdollah, F., Chun, F. K. H., Kibel, A. S., Tucker-Seeley, R. D., Kantoff, P. W., Lipsitz, S. R., Menon, M., Nguyen, P. L. & Trinh, Q-D., 01.01.2016, In: JAMA ONCOL. 2, 1, p. 85-93 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  90. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision-Making

    Frego, N., Beatrici, E., Labban, M., Stone, B. V., Filipas, D. K., Koelker, M., Lughezzani, G., Buffi, N. M., Osman, N. Y., Lipsitz, S. R., Sammon, J. D., Kibel, A. S., Trinh, Q-D. & Cole, A. P., 01.2024, In: AM J PREV MED. 66, 1, p. 27-36 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  91. Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis

    Gild, P., Wankowicz, S. A., Sood, A., von Landenberg, N., Friedlander, D. F., Alanee, S., Chun, F. K. H., Fisch, M., Menon, M., Trinh, Q-D., Bellmunt, J. & Abdollah, F., 10.2018, In: UROL ONCOL-SEMIN ORI. 36, 10, p. 469.e1-469.e11

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  92. Radiation therapy after radical prostatectomy is associated with higher other-cause mortality

    Würnschimmel, C., Wenzel, M., Chierigo, F., Flammia, R. S., Horlemann, B., Tian, Z., Saad, F., Briganti, A., Shariat, S. F., Gallucci, M., Suardi, N., Chun, F. K. H., Tilki, D., Graefen, M. & Karakiewicz, P. I., 05.2022, In: CANCER CAUSE CONTROL. 33, 5, p. 769-777 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  93. Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.

    Liberman, D., Alasker, A., Sun, M., Ismail, S., Lughezzani, G., Jeldres, C., Budäus, L., Thuret, R., Shariat, S. F., Widmer, H., Perrotte, P., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2011, In: BJU INT. 107, 6, p. 905-911 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  94. Radical prostatectomy after previous TUR-P: Oncological, surgical, and functional outcomes

    Pompe, R. S., Leyh-Bannurah, S-R., Preisser, F., Salomon, G., Graefen, M., Huland, H., Karakiewicz, P. I. & Tilki, D., 12.2018, In: UROL ONCOL-SEMIN ORI. 36, 12, p. 527.e21-527.e28

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  95. Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.

    Trinh, Q-D., Schmitges, J., Sun, M., Shariat, S. F., Sukumar, S., Bianchi, M., Tian, Z., Jeldres, C., Sammon, J., Perrotte, P., Graefen, M., Peabody, J. O., Menon, M. & Karakiewicz, P. I., 2011, In: J UROLOGY. 186, 5, p. 1849-1854 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  96. Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center

    Würnschimmel, C., Wenzel, M., Wang, N., Tian, Z., Karakiewicz, P. I., Graefen, M., Huland, H. & Tilki, D., 12.2021, In: UROL ONCOL-SEMIN ORI. 39, 12, p. 830.e17-830.e26

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  97. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.

    Steuber, T., Budäus, L., Walz, J., Zorn, K. C., Schlomm, T., Chun, F., Ahyai, S., Fisch, M., Sauter, G., Huland, H., Graefen, M. & Haese, A., 2011, In: BJU INT. 107, 11, p. 1755-1761 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  98. Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population-based study

    Stolzenbach, L. F., Deuker, M., Collà-Ruvolo, C., Nocera, L., Tian, Z., Maurer, T., Steuber, T., Tilki, D., Briganti, A., Saad, F., Chun, F. K., Graefen, M. & Karakiewicz, P. I., 08.2021, In: INT J UROL. 28, 8, p. 834-839 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  99. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression

    Schiffmann, J., Salomon, G., Tilki, D., Budäus, L., Karakiewicz, P. I., Leyh-Bannurah, S-R., Pompe, R. S., Haese, A., Heinzer, H., Huland, H., Graefen, M. & Tennstedt, P., 05.2017, In: UROL ONCOL-SEMIN ORI. 35, 5, p. 243-249 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  100. Radioligand Therapy With 177 Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile

    Demirkol, M. O., Esen, B., Seymen, H., Şen, M., Uçar, B., Kurtuldu, S., Mandel, N. M., Bavbek, S., Falay, O., Tilki, D. & Esen, T., 01.12.2023, In: CLIN NUCL MED. 48, 12, p. e564-e569

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  101. Rapid quantification of telomerase activity employing an improved real-time telomeric repeat amplification protocol in clinical tissue samples eliminates interference by PCR inhibitors

    Schriefer, P., Günes, C. & Wege, H., 2011, In: J Cancer Sci Ther. 3, 8, p. 176-180 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1...8 9 10 11 12 13 14 15 ...19 Next